Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-bimzelx-bimekizumab-bkzx-data-at-acr-convergence-2024-highlights-ucbs-efforts-to-deliver-differentiated-care-for-patients-with-psoriatic-arthritis-and-axial-spondyloarthritis-302306120.html

13 Nov 2024
// EXPRESSPHARMA
https://www.expresspharma.in/ucb-and-biogens-dapirolizumab-pegol-paves-path-for-systemic-lupus-erythematosus-treatment-2/

01 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/ucbs-tau-drug-flunks-phase-2-alzheimers-trial-days-after-roches-exit-120m-bet

07 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-positive-topline-results-from-phase-iii-study-of-ucbbiogens-dapirolizumab-pegol-brings-a-ray-of-hope-in-systemic-lupus-erythematosus-therapeutic-space--delveinsight-302268558.html

27 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-announces-late-breaking-two-year-data-for-bimzelx-bimekizumab-bkzx-in-moderate-to-severe-hidradenitis-suppurativa-at-eadv-2024-302260703.html

25 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-presents-new-4-year-data-for-bimzelx-bimekizumab-bkzx-in-moderate-to-severe-plaque-psoriasis-at-eadv-2024-302257850.html
ABOUT THIS PAGE
UCB Farchim SA is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of Brivaracetam bulk offered by UCB Farchim SA
Find a price of Cetirizine Dihydrochloride bulk offered by UCB Farchim SA
Find a price of Levetiracetam bulk offered by UCB Farchim SA
Find a price of Levocetirizine Dihydrochloride bulk offered by UCB Farchim SA